TBPHTheravance Biopharma, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 22339
Ticker: TBPH
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2014-05-16
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TBPH

Detail

Enriched 2026-08-14 20:47

Market cap: $878,465,317.68
Shares outstanding (class): 51,553,005
Shares outstanding (weighted): 51,918,754
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 90
Location: GEORGE TOWN, GRAND CAYMAN, CA
Homepage: https://www.theravance.com
Description: Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Market cap and share counts drift.

Funds holding this security

110 funds · 110 positions · $84.76M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$21.50M	0.00%	1,324,682 NS	TICKER
iShares Russell 2000 ETF iShares Trust	IWM	$15.24M	0.02%	938,715 NS	TICKER
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$6.71M	0.01%	413,723 NS	TICKER
iShares Biotechnology ETF iShares Trust	IBB	$5.74M	0.07%	353,652 NS	TICKER
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$4.36M	1.42%	268,815 NS	TICKER
iShares Russell 2000 Growth ETF iShares Trust	IWO	$4.07M	0.03%	250,562 NS	TICKER
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$3.39M	0.51%	208,783 NS	TICKER
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$1.68M	0.17%	103,389 NS	TICKER
iShares Micro-Cap ETF iShares Trust	IWC	$1.57M	0.13%	96,665 NS	TICKER
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$1.53M	0.04%	94,511 NS	TICKER
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.11M	0.01%	68,260 NS	TICKER
Master Small Cap Index Series Quantitative Master Series LLC	—	$998.9K	0.02%	61,547 NS	TICKER
BlackRock Advantage Small Cap Growth Fund BlackRock Funds	—	$867.8K	0.13%	53,469 NS	TICKER
Principal U.S. Small-Cap ETF Principal Exchange-Traded Funds	PSC	$805.7K	0.05%	49,640 NS	TICKER
Franklin U.S. Small Cap Equity Fund Legg Mason Global Asset Management Trust	—	$768.6K	0.65%	47,355 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERTBPH
CIK0001583107
ISINKYG8807B1068
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Theravance Biopharma is a biopharmaceutical company classified under SIC 2834, indicating pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.